Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Bill Haynes joins us with the title of Visiting Professor of Metabolic Medicine. Professor Haynes is currently also the site head and Vice President of the Novo Nordisk Research Centre in Oxford, and was previously the Head and Vice President for Diabetes Biosciences at AstraZeneca. He has also been the Director of Translational Medicine (Cardiovascular and Metabolic) at the Novartis Institutes for Biomedical Research, preceded by 18 years at the University of Iowa, where he finished as the Professor for Cardiovascular Medicine and Endocrinology. 

A warm welcome to Professor Haynes in his new Visiting Professor position. 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.

Iron integral to the development of life on Earth – and the possibility of life on other planets

A collaboration between researchers at the MRC WIMM/RDM and Department of Earth Sciences uncovers the importance of iron for the development of complex life on Earth.